The Use of Osteobiologics in Single versus Multi-Level Anterior Cervical Discectomy and Fusion: A Systematic Review.

Authors:
Hoffmann J; Ricciardi GA; Yurac R; Meisel HJ; Buser Z and 3 more

Journal:
Global Spine J

Publication Year: 2024

DOI:
10.1177/21925682221136482

PMCID:
PMC10913903

PMID:
38421334

Journal Information

Journal Title: Global Spine J

Detailed journal information not available.

Publication Details

Subject Category: Clinical Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

Evidence found in paper:

"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This supplement was organized and financially supported by AO Spine through the AO Spine Knowledge Forum Degenerative, a focused group of international spine experts."

Evidence found in paper:

"The systematic review was registered into the PROSPERO database under number CRD42020199006. A PICO answering the main question was drafted by the team lead and co-lead and discussed with the entire review team via video conferencing. The PICO was subsequently reviewed by the AO-GO core team, to be able to seamlessly integrate it with the other 12 systematic reviews performed, in relation to the guideline development. The full PICO can be found as a supplemental document, Table 1. In short, we included adult patients between ages 18 and 80 years old with herniated or degenerative cervical neck discs. Exclusion criteria were: history of tumor; infection; spinal cord injury; trauma or fracture; skeletally immature patients or patients with scoliosis or other cervical deformity. Intervention was multi-level ACDF with cage and/or anterior plating and the use of an osteobiologic (see supplemental documents, Table 2). The comparator was single level ACDF with cage and/or anterior plating combined with iliac crest bone graft (ICBG) or allograft. Our primary outcome measure was fusion, determined either by CT or flexion/extension X-rays. Secondary outcome measures were patient reported outcome measures (PROMs). Only articles published after 2000 were considered for review."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025